What is the debt of Medincell this year?
Medincell has a debt level of 48.16 EUR this year.
Medincell Debt 2024
Medincell Debt
48.16 EUR
Medincell Dividend yield
Ticker
MEDCL.PA
ISIN
FR0004065605
WKN
A2N6VA
In 2024, Medincell's total debt was 48.16 EUR, a 116.34% change from the 22.26 EUR total debt recorded in the previous year.
Medincell Aktienanalyse
What does Medincell do?
Medincell SA is a leading biotechnology company based in Montpellier, France, specializing in the development and manufacturing of innovative drugs based on its proprietary Intellisome® technology platform. The company was founded in 1999 by Dr. Christophe Douat and has since built an impressive portfolio of products and services. Medincell's business model is based on the development and manufacturing of extended-release drugs through the integration of drugs into the Intellisome® technology platform. This is a novel concept based on the use of polymers that are capable of controlling and slowing down the release of drugs. This allows medications to be administered in a specific dosage and duration, providing greater effectiveness and tolerability for the patient. Medincell has several business areas, including the development of drugs for the treatment of central nervous system (CNS) disorders, including schizophrenia, depression, and chronic pain. The company is also working on the development of drugs for the treatment of infectious diseases and cancer, as well as the development of new technologies for drug manufacturing. Medincell's products include a range of drugs, including Long-Acting Risperidone (a depot preparation for the treatment of schizophrenia), Long-Acting Cabergoline (for the treatment of Parkinson's), and Long-Acting Naltrexone (for the treatment of alcohol and drug addiction). The company also has partnerships with other pharmaceutical companies such as Pierre Fabre, Sanofi, Janssen, and Pfizer for the development of products based on its Intellisome® technology platform. Another important area of Medincell is its service for drug development based on the Intellisome® technology platform. The company offers customers comprehensive support in the development, manufacturing, and approval of extended-release drugs. Customers can choose from a wide range of services, ranging from the identification of active ingredients to the implementation of clinical trials. Overall, Medincell has achieved impressive success in the launch of its products and services based on the Intellisome® technology platform. The company has won several awards for its innovative products and services in the pharmaceutical industry, including the Innovation Award from the European Society of Clinical Microbiology and Infectious Diseases in 2018 and the Excellence in Specialty Pharmaceuticals Award from BioPharm America in 2019. In summary, Medincell SA is a leading company in the biotechnology industry specializing in the development and manufacturing of extended-release drugs based on its Intellisome® technology platform. With an impressive range of products and services and partnerships with several renowned pharmaceutical companies, the company has a promising future as a key player in the pharmaceutical industry. Medincell ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Medincell's Debt Structure
Medincell's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Medincell's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Medincell’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Medincell’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Medincell Stock
What was the debt of Medincell compared to the previous year?
The debt of Medincell has increased by 116.34% compared to the previous year increased.
What are the consequences of high debt for investors in Medincell?
High debt can pose a risk for investors of Medincell, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Medincell?
Low debt means that Medincell has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Medincell affect the company?
An increase in debt of Medincell can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Medincell affect the company?
A reduction in debt of Medincell can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Medincell?
Some factors that can influence the debt of Medincell include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Medincell so important for investors?
The debts of Medincell are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Medincell take to change the debt?
To change the debt, Medincell can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Medincell pay?
Over the past 12 months, Medincell paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medincell is expected to pay a dividend of 0 EUR.
What is the dividend yield of Medincell?
The current dividend yield of Medincell is .
When does Medincell pay dividends?
Medincell pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Medincell?
Medincell paid dividends every year for the past 0 years.
What is the dividend of Medincell?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Medincell located?
Medincell is assigned to the 'Health' sector.
Wann musste ich die Aktien von Medincell kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Medincell from 5/17/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.
When did Medincell pay the last dividend?
The last dividend was paid out on 5/17/2024.
What was the dividend of Medincell in the year 2023?
In the year 2023, Medincell distributed 0 EUR as dividends.
In which currency does Medincell pay out the dividend?
The dividends of Medincell are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Medincell stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Medincell
Our stock analysis for Medincell Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medincell Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
